Sheryl Koski

7.1k citations
35 papers · 4.9k · 3 hit papers · h-index 16

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Surgical Treatments

Papers in

    • Colorectal Cancer Treatments and Studies 21
    • Cancer Treatment and Pharmacology 10
    • Cancer Immunotherapy and Biomarkers 4
    • Pancreatic and Hepatic Oncology Research 4
    • Gastric Cancer Management and Outcomes 14

Sheryl Koski

35 papers receiving 4.7k citations

Sheryl Koski's Hit Papers

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment 2009 · 856 citations
8560+6+12Years since publication50010001.5k2.0k

Peers

Sheryl Koski
Comparison fields: 5 of 118
  • Hepatology 1.1k
  • Oncology 3.6k
  • Geriatrics and Gerontology 316
  • Pulmonary and Respiratory Medicine 1.4k
  • Physiology 782
Replace G. Ganem with:
G. Ganem France
Per Pfeiffer Denmark
Irene Floriani Italy
Miriam Koopman Netherlands
Frans Erdkamp Netherlands
Colin S. McArdle United Kingdom
Jean‐François Seitz France
Blasé N. Polite United States
Thomas Aparicio France
J A Mailliard United States
Sheryl Koski relative to G. Ganem France G. Ganem's profile →
Citations per field
00.5×4.4×
G. Ganem · 1×
Citations per year

Countries citing papers authored by Sheryl Koski

Since Specialization
Citations

This map shows the geographic impact of Sheryl Koski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheryl Koski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheryl Koski more than expected).

Fields of papers citing papers by Sheryl Koski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheryl Koski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheryl Koski. The network helps show where Sheryl Koski may publish in the future.

Co-authors

The 25 scholars most cited alongside Sheryl Koski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sheryl Koski Line = papers co-authored together Sheryl Koski links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Hit paper breakdown →
20082275
2
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Hit paper breakdown →
2009856
3
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Hit paper breakdown →
2008652
4 2011178
5 2012163
6 2000101
7 200986
8 200783
9 201277
10 201675
11 200763
12 197141
13 201937
14 201120
15 201517
16 201917
17 200415
18 202314
19 201613
20 202011

About Sheryl Koski

Sheryl Koski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Physiology, having authored 35 papers that have together received 4.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Gastric Cancer Management and Outcomes (14 papers), Cancer Treatment and Pharmacology (10 papers), Genetic factors in colorectal cancer (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Hepatology (1.1k citations), Oncology (3.6k citations), Geriatrics and Gerontology (316 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Physiology (782 citations). Sheryl Koski has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Stephen Clarke, Leonard B. Saltz, Jim Cassidy, Félix Couture, Tsai‐Shen Yang, Fernando Rivera and Florin Sirzén. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, International Journal of Colorectal Disease, Annals of Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact